Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szombathely – page 10

173 clinical trials in Szombathely, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szombathely at a glance
173
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

173 trials in Szombathely

Open in trial search

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

A Study of XC001 Gene Therapy with Bypass Surgery for Patients with Coronary Artery Disease and Weakened Heart Function at Risk for Incomplete Treatment

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Xylocor Therapeutics Inc.

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 1815368
  • Sponsor:Boehringer Ingelheim International GmbH

Colitis ulcerative

Not recruiting

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Cardiac failure

Not recruiting

Study on COR-1167 for Patients with Worsening Heart Failure

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:COR-1167 sodium
  • Sponsor:Corteria Pharmaceuticals

Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Obesity+1

Not recruiting

Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szombathely

What the registry says about research in the country

01 Respiratory Medicine

Clinical trials focusing on respiratory conditions, particularly investigating new treatments for asthma and COPD. Studies evaluate innovative therapies including atuliflapon and dupilumab for improving lung function and disease control.

  • Moderate to severe asthma management
  • COPD treatment optimization
  • Lung function preservation

Research aims to enhance therapeutic options for patients with uncontrolled respiratory conditions.

02 Dermatology & Immunology

Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa.

  • Advanced biologics evaluation
  • Inflammatory disease management
  • Novel therapeutic approaches

Studies focus on developing targeted treatments for chronic inflammatory conditions.

03 Oncology & Hematology

Groundbreaking research in cancer treatment and blood disorders, including studies on breast cancer, lymphoma, and multiple myeloma. Investigations of targeted therapies and combination treatments.

  • Breast cancer therapy
  • Lymphoma treatment
  • Multiple myeloma management

Focus on improving survival rates and treatment outcomes in various cancer types.

04 Gastroenterology

Clinical research examining treatments for inflammatory bowel diseases, including studies on Crohn's Disease and Ulcerative Colitis. Evaluation of combination therapies and novel biological agents.

  • IBD treatment advancement
  • Combination therapy assessment
  • Disease control optimization

Emphasis on improving quality of life for patients with chronic digestive conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.